CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 102 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $389,000 | -80.1% | 39,550 | -79.8% | 0.01% | -81.5% |
| Q2 2020 | $1,951,000 | +12.6% | 195,997 | 0.0% | 0.03% | -3.6% |
| Q1 2020 | $1,733,000 | -3.9% | 195,997 | 0.0% | 0.03% | +55.6% |
| Q4 2019 | $1,804,000 | +54.6% | 195,997 | -1.2% | 0.02% | +38.5% |
| Q3 2019 | $1,167,000 | -51.0% | 198,441 | 0.0% | 0.01% | -50.0% |
| Q2 2019 | $2,382,000 | +137.3% | 198,441 | +138.7% | 0.03% | +136.4% |
| Q1 2019 | $1,004,000 | -3.8% | 83,122 | 0.0% | 0.01% | -15.4% |
| Q4 2018 | $1,044,000 | -15.8% | 83,122 | -0.5% | 0.01% | +8.3% |
| Q3 2018 | $1,240,000 | -11.5% | 83,547 | +0.4% | 0.01% | -14.3% |
| Q2 2018 | $1,401,000 | -26.1% | 83,247 | +0.5% | 0.01% | -26.3% |
| Q1 2018 | $1,896,000 | -17.4% | 82,803 | -6.7% | 0.02% | -13.6% |
| Q4 2017 | $2,295,000 | +70.5% | 88,705 | -2.8% | 0.02% | +100.0% |
| Q3 2017 | $1,346,000 | +4.0% | 91,262 | -1.6% | 0.01% | 0.0% |
| Q2 2017 | $1,294,000 | – | 92,787 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |